BLUE BIRD CORP (BLBD) Fundamental Analysis & Valuation

NASDAQ:BLBD • US0953061068

Current stock price

64.0222 USD
-0.09 (-0.14%)
Last:

This BLBD fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. BLBD Profitability Analysis

1.1 Basic Checks

  • In the past year BLBD was profitable.
  • BLBD had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: BLBD reported negative net income in multiple years.
  • The reported operating cash flow has been mixed in the past 5 years: BLBD reported negative operating cash flow in multiple years.
BLBD Yearly Net Income VS EBIT VS OCF VS FCFBLBD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M

1.2 Ratios

  • BLBD's Return On Assets of 20.20% is amongst the best of the industry. BLBD outperforms 99.24% of its industry peers.
  • BLBD has a better Return On Equity (47.81%) than 97.71% of its industry peers.
  • The Return On Invested Capital of BLBD (31.20%) is better than 99.24% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for BLBD is significantly above the industry average of 10.06%.
  • The last Return On Invested Capital (31.20%) for BLBD is above the 3 year average (29.27%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 20.2%
ROE 47.81%
ROIC 31.2%
ROA(3y)15.41%
ROA(5y)6.73%
ROE(3y)58.56%
ROE(5y)N/A
ROIC(3y)29.27%
ROIC(5y)N/A
BLBD Yearly ROA, ROE, ROICBLBD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K

1.3 Margins

  • The Profit Margin of BLBD (8.65%) is better than 70.23% of its industry peers.
  • In the last couple of years the Profit Margin of BLBD has grown nicely.
  • With a decent Operating Margin value of 11.46%, BLBD is doing good in the industry, outperforming 61.07% of the companies in the same industry.
  • BLBD's Operating Margin has improved in the last couple of years.
  • BLBD's Gross Margin of 20.97% is on the low side compared to the rest of the industry. BLBD is outperformed by 70.99% of its industry peers.
  • BLBD's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 11.46%
PM (TTM) 8.65%
GM 20.97%
OM growth 3YN/A
OM growth 5Y35.18%
PM growth 3YN/A
PM growth 5Y44.13%
GM growth 3Y65.07%
GM growth 5Y13.39%
BLBD Yearly Profit, Operating, Gross MarginsBLBD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10 15 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. BLBD Health Analysis

2.1 Basic Checks

  • BLBD has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • Compared to 1 year ago, BLBD has less shares outstanding
  • Compared to 5 years ago, BLBD has more shares outstanding
  • BLBD has a better debt/assets ratio than last year.
BLBD Yearly Shares OutstandingBLBD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
BLBD Yearly Total Debt VS Total AssetsBLBD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

  • An Altman-Z score of 7.36 indicates that BLBD is not in any danger for bankruptcy at the moment.
  • BLBD has a Altman-Z score of 7.36. This is amongst the best in the industry. BLBD outperforms 87.79% of its industry peers.
  • BLBD has a debt to FCF ratio of 0.55. This is a very positive value and a sign of high solvency as it would only need 0.55 years to pay back of all of its debts.
  • The Debt to FCF ratio of BLBD (0.55) is better than 90.84% of its industry peers.
  • A Debt/Equity ratio of 0.31 indicates that BLBD is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.31, BLBD is in the better half of the industry, outperforming 62.60% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 0.55
Altman-Z 7.36
ROIC/WACC2.95
WACC10.58%
BLBD Yearly LT Debt VS Equity VS FCFBLBD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M

2.3 Liquidity

  • A Current Ratio of 1.81 indicates that BLBD should not have too much problems paying its short term obligations.
  • The Current ratio of BLBD (1.81) is worse than 64.12% of its industry peers.
  • BLBD has a Quick Ratio of 1.21. This is a normal value and indicates that BLBD is financially healthy and should not expect problems in meeting its short term obligations.
  • BLBD has a Quick ratio of 1.21. This is comparable to the rest of the industry: BLBD outperforms 48.09% of its industry peers.
Industry RankSector Rank
Current Ratio 1.81
Quick Ratio 1.21
BLBD Yearly Current Assets VS Current LiabilitesBLBD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. BLBD Growth Analysis

3.1 Past

  • BLBD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 28.08%, which is quite impressive.
  • BLBD shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 39.87% yearly.
  • The Revenue has grown by 11.61% in the past year. This is quite good.
  • The Revenue has been growing by 10.98% on average over the past years. This is quite good.
EPS 1Y (TTM)28.08%
EPS 3YN/A
EPS 5Y39.87%
EPS Q2Q%8.7%
Revenue 1Y (TTM)11.61%
Revenue growth 3Y22.73%
Revenue growth 5Y10.98%
Sales Q2Q%6.12%

3.2 Future

  • BLBD is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.23% yearly.
  • BLBD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.93% yearly.
EPS Next Y5.61%
EPS Next 2Y8.34%
EPS Next 3Y6.23%
EPS Next 5YN/A
Revenue Next Year5.81%
Revenue Next 2Y6.32%
Revenue Next 3Y4.72%
Revenue Next 5Y5.93%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BLBD Yearly Revenue VS EstimatesBLBD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
BLBD Yearly EPS VS EstimatesBLBD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 4

More info and screens

Find the best growth stocksShow best growing peers

6

4. BLBD Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 14.32, which indicates a correct valuation of BLBD.
  • 90.84% of the companies in the same industry are more expensive than BLBD, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of BLBD to the average of the S&P500 Index (26.77), we can say BLBD is valued slightly cheaper.
  • The Price/Forward Earnings ratio is 12.42, which indicates a correct valuation of BLBD.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of BLBD indicates a rather cheap valuation: BLBD is cheaper than 93.13% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 21.75. BLBD is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 14.32
Fwd PE 12.42
BLBD Price Earnings VS Forward Price EarningsBLBD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • BLBD's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. BLBD is cheaper than 79.39% of the companies in the same industry.
  • BLBD's Price/Free Cash Flow ratio is rather cheap when compared to the industry. BLBD is cheaper than 90.08% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.5
EV/EBITDA 10.91
BLBD Per share dataBLBD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • BLBD has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.56
PEG (5Y)0.36
EPS Next 2Y8.34%
EPS Next 3Y6.23%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BLBD Dividend Analysis

5.1 Amount

  • No dividends for BLBD!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BLBD Fundamentals: All Metrics, Ratios and Statistics

BLUE BIRD CORP

NASDAQ:BLBD (5/1/2026, 9:48:43 AM)

64.0222

-0.09 (-0.14%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Industry Strength85.71
Industry Growth69.57
Earnings (Last)02-04
Earnings (Next)05-06
Inst Owners115.9%
Inst Owner Change0.32%
Ins Owners0.55%
Ins Owner Change4.66%
Market Cap2.20B
Revenue(TTM)1.50B
Net Income(TTM)129.75M
Analysts82.86
Price Target68.08 (6.34%)
Short Float %11.24%
Short Ratio9.42
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)22.62%
Min EPS beat(2)20.09%
Max EPS beat(2)25.16%
EPS beat(4)3
Avg EPS beat(4)16.38%
Min EPS beat(4)-0.8%
Max EPS beat(4)25.16%
EPS beat(8)7
Avg EPS beat(8)30.67%
EPS beat(12)11
Avg EPS beat(12)59.19%
EPS beat(16)12
Avg EPS beat(16)-79.92%
Revenue beat(2)2
Avg Revenue beat(2)2.88%
Min Revenue beat(2)0.25%
Max Revenue beat(2)5.51%
Revenue beat(4)3
Avg Revenue beat(4)2.03%
Min Revenue beat(4)-0.95%
Max Revenue beat(4)5.51%
Revenue beat(8)5
Avg Revenue beat(8)3.11%
Revenue beat(12)9
Avg Revenue beat(12)4.96%
Revenue beat(16)12
Avg Revenue beat(16)7.06%
PT rev (1m)0.38%
PT rev (3m)4.71%
EPS NQ rev (1m)0.44%
EPS NQ rev (3m)-5.15%
EPS NY rev (1m)0%
EPS NY rev (3m)5.12%
Revenue NQ rev (1m)-0.41%
Revenue NQ rev (3m)-7.67%
Revenue NY rev (1m)-0.25%
Revenue NY rev (3m)0.97%
Valuation
Industry RankSector Rank
PE 14.32
Fwd PE 12.42
P/S 1.46
P/FCF 13.5
P/OCF 11.78
P/B 8.09
P/tB 10.39
EV/EBITDA 10.91
EPS(TTM)4.47
EY6.98%
EPS(NY)5.15
Fwd EY8.05%
FCF(TTM)4.74
FCFY7.41%
OCF(TTM)5.44
OCFY8.49%
SpS43.72
BVpS7.91
TBVpS6.16
PEG (NY)2.56
PEG (5Y)0.36
Graham Number28.2124 (-55.93%)
Profitability
Industry RankSector Rank
ROA 20.2%
ROE 47.81%
ROCE 42.19%
ROIC 31.2%
ROICexc 76.78%
ROICexgc 120.5%
OM 11.46%
PM (TTM) 8.65%
GM 20.97%
FCFM 10.85%
ROA(3y)15.41%
ROA(5y)6.73%
ROE(3y)58.56%
ROE(5y)N/A
ROIC(3y)29.27%
ROIC(5y)N/A
ROICexc(3y)58.87%
ROICexc(5y)N/A
ROICexgc(3y)104.89%
ROICexgc(5y)N/A
ROCE(3y)39.57%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y47.59%
ROICexc growth 3YN/A
ROICexc growth 5Y50.42%
OM growth 3YN/A
OM growth 5Y35.18%
PM growth 3YN/A
PM growth 5Y44.13%
GM growth 3Y65.07%
GM growth 5Y13.39%
F-Score7
Asset Turnover2.33
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 0.55
Debt/EBITDA 0.45
Cap/Depr 151.15%
Cap/Sales 1.58%
Interest Coverage 26.47
Cash Conversion 99.4%
Profit Quality 125.35%
Current Ratio 1.81
Quick Ratio 1.21
Altman-Z 7.36
F-Score7
WACC10.58%
ROIC/WACC2.95
Cap/Depr(3y)101.02%
Cap/Depr(5y)87.95%
Cap/Sales(3y)1.14%
Cap/Sales(5y)1.2%
Profit Quality(3y)226.25%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)28.08%
EPS 3YN/A
EPS 5Y39.87%
EPS Q2Q%8.7%
EPS Next Y5.61%
EPS Next 2Y8.34%
EPS Next 3Y6.23%
EPS Next 5YN/A
Revenue 1Y (TTM)11.61%
Revenue growth 3Y22.73%
Revenue growth 5Y10.98%
Sales Q2Q%6.12%
Revenue Next Year5.81%
Revenue Next 2Y6.32%
Revenue Next 3Y4.72%
Revenue Next 5Y5.93%
EBIT growth 1Y27.81%
EBIT growth 3YN/A
EBIT growth 5Y50.02%
EBIT Next Year34.98%
EBIT Next 3Y14.46%
EBIT Next 5YN/A
FCF growth 1Y80.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y85.98%
OCF growth 3YN/A
OCF growth 5Y119.48%

BLUE BIRD CORP / BLBD Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for BLUE BIRD CORP?

ChartMill assigns a fundamental rating of 6 / 10 to BLBD.


Can you provide the valuation status for BLUE BIRD CORP?

ChartMill assigns a valuation rating of 6 / 10 to BLUE BIRD CORP (BLBD). This can be considered as Fairly Valued.


How profitable is BLUE BIRD CORP (BLBD) stock?

BLUE BIRD CORP (BLBD) has a profitability rating of 7 / 10.


Can you provide the financial health for BLBD stock?

The financial health rating of BLUE BIRD CORP (BLBD) is 7 / 10.


How sustainable is the dividend of BLUE BIRD CORP (BLBD) stock?

The dividend rating of BLUE BIRD CORP (BLBD) is 0 / 10 and the dividend payout ratio is 0%.